(Q34272224)

1 August 2017

1 reference

title

The pharmacology of psilocybin (English)

1 reference

substance-related disorder

1 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578010

25 March 2024

author name string

Torsten Passie

1

1 reference

1 August 2017

Juergen Seifert

2

1 reference

1 August 2017

Udo Schneider

3

1 reference

1 August 2017

Hinderk M. Emrich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14578010

25 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14578010

25 March 2024

publication date

1 October 2002

1 reference

full work available at URL

1 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1080%2F1355621021000005937

1 reference

https://api.crossref.org/works/10.1080/1355621021000005937

https://onlinelibrary.wiley.com/doi/pdf/10.1080/1355621021000005937

25 March 2024

1 reference

https://api.crossref.org/works/10.1080/1355621021000005937

25 March 2024

1 reference

1 August 2017

volume

7

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

357-364

1 reference

Hallucinogens, serotonin and obsessive-compulsive disorder

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen Rauschpilzen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Comparison of the reactions induced by psilocybin and LSD-25 in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Cross tolerance between LSD and psilocybin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

Serotonin-dopamine interaction and its relevance to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1355621021000005937

The action of psilocybin on the rabbit brain

21 January 2018

18

1 reference

https://api.crossref.org/works/10.1080/1355621021000005937

Clinical, biochemical and psychologic effects of psilocybin

25 March 2024

25

1 reference

https://api.crossref.org/works/10.1080/1355621021000005937

Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and‡ 9-THC using the micronucleus test

25 March 2024

26

1 reference

https://api.crossref.org/works/10.1080/1355621021000005937

Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man

25 March 2024

29

1 reference

https://api.crossref.org/works/10.1080/1355621021000005937

Handling of psilocybin and psilocin by everted sacs of rat jejunum and colon

25 March 2024

31

1 reference

https://api.crossref.org/works/10.1080/1355621021000005937

Comparison of psilocin with psilocybin, mescaline and LSD-25

25 March 2024

34

1 reference

https://api.crossref.org/works/10.1080/1355621021000005937

The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist states

25 March 2024

40

1 reference

https://api.crossref.org/works/10.1080/1355621021000005937

25 March 2024

Identifiers

1 reference

1 August 2017

1 reference